Use of Bivalirudin for Anticoagulation in Patients With Extracorporeal Membrane Oxygenation

NARecruitingINTERVENTIONAL

Enrollment

154

Participants

Timeline

Start Date

June 3, 2024

Primary Completion Date

December 1, 2026

Study Completion Date

December 31, 2026

Conditions

Extracorporeal Membrane Oxygenation Complication

Interventions

DRUG

bivalirudin

bivalirudin as an anticoagulant

DRUG

unfractionated heparin

unfractionated heparin as an anticoagulant

Trial Locations (1)

RECRUITING

Beijing Anzhen Hospital, Beijing

All Listed Sponsors

lead

Xiaotong Hou

OTHER